Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom
Year of publication: |
2014
|
---|---|
Authors: | Samyshkin, Yevgeniy ; Kotchie, Robert W. ; Mörk, Ann-Christin ; Briggs, Andrew Harvey ; Bateman, Eric D. |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 15.2014, 1, p. 69-82
|
Subject: | COPD | Cost-effectiveness analysis | Chronic-obstructive pulmonary disease | Roflumilast | Exacerbations | Großbritannien | United Kingdom | Kosten-Wirksamkeits-Analyse | Krankheit | Disease | Gesundheitskosten | Health care costs | Gesundheitswesen | Health care system | Kosten-Nutzen-Analyse | Cost-benefit analysis |
-
Wilson, Michele R., (2018)
-
Samyshkin, Yevgeniy, (2014)
-
Cost-effectiveness and estimated health benefits of treating patients with vitamin D in pre-dialysis
Snyder, Sophie, (2020)
- More ...
-
Samyshkin, Yevgeniy, (2014)
-
Mendelian randomization: Estimation of inpatient hospital costs attributable to obesity
Dick, Katherine, (2021)
-
Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences
Crott, Ralph, (2010)
- More ...